The Philippines FDA has extended its temporary suspension of 2025 medical device registration fees, granting manufacturers an additional 60 working days to register at legacy rates. This move, formalized under Department Circular No. 2025-0382, offers continued cost savings and a strategic window for market entry while the agency completes its review of the updated fee schedule.
Following our previous update on “Philippines FDA Temporarily Suspends Medical Device Registration Fees in 2025” (July 24), the Philippines FDA has issued Department Circular No. 2025-0382 on 5th September, 2025, extending the temporary suspension of medical device registration fees. This extension provides manufacturers with an additional 60 working days to register at the legacy fee rates, offering continued cost savings and a strategic window for market entry.
The FDA initially suspended the increased medical device registration fees under Department Circular No. 2025-0240 for 60 working days starting June 10, 2025. This temporary suspension allowed the agency to conduct stakeholder consultations and internal reviews of the new fee schedule under Administrative Order No. 2024-0016.
Considering ongoing consultations and internal review, the FDA has extended the suspension for an additional 60 working days. This extension begins immediately after the initial suspension period, allowing the FDA sufficient time to finalize internal processes and address stakeholder concerns while maintaining the opportunity to register at the old fee rates.
Manufacturers should act promptly to take advantage of the extended suspension. Initiating registration during this period maximizes cost savings and avoids the higher fees once the suspension ends.
For full details on the extension, review the official Department Circular No. 2025-0382.
Philippines FDA issued Department Circular No. 2025-0382, extending the temporary suspension of 2025 medical device registration fees for an additional 60 working days. This follows the initial suspension under DC No. 2025-0240 and allows manufacturers to continue registering at legacy fee rates. The extension ensures sufficient time for stakeholder consultations and internal review, providing cost savings and strategic registration opportunities.
Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us